Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2018

Open Access 01.12.2018 | Case report

Carcinosarcoma of the parotid gland with abdominal metastasis: a case report and review of literature

verfasst von: Chang Gok Woo, Seung-Myoung Son

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2018

Abstract

Background

Carcinosarcoma of the salivary gland is a rare aggressive malignant tumor, composed of a mixture of carcinomatous and sarcomatous components. The most common metastatic sites include the lungs, bones, and central nervous system.

Case presentation

This report describes a rare case of carcinosarcoma of the parotid gland with an osteosarcoma as sarcomatous component in a 72-year-old man who had a history of low anterior resection for rectal cancer. Six months after parotidectomy, he presented abdominal pain as a symptom of abdominal metastasis by the sarcomatous component. At that time, the possibility of abdominal metastasis was overlooked because of the history of abdominal surgery. After several days of conservative treatment, emergency laparotomy was done. However, he died of acute respiratory distress syndrome.

Conclusions

Awareness of the possibility of abdominal metastasis by salivary carcinosarcoma may help in managing patients with a history of abdominal surgery.
Abkürzungen
CT
Computed tomography
ARDS
Acute respiratory distress syndrome

Background

Carcinosarcoma, also called true malignant mixed tumor, is an aggressive malignant neoplasm of the salivary gland. It is an extremely rare malignancy, comprising 0.04 to 0.16% of all salivary gland tumors and 0.4% of all malignant salivary gland neoplasms. The mean age at presentation is in the sixth to seventh decade of life, but can range from 14 to 87 years [13]. Although de novo carcinosarcomas can occur in the salivary gland, many patients have a history of long standing or recurrent pleomorphic adenomas, a condition described as carcinosarcoma ex pleomorphic adenoma [46]. Most of these lesions arise in the major salivary glands, with two thirds in the parotid glands [2]. Patients typically present with a rapidly growing mass.
These tumors are composed of a mixture of distinct carcinomatous and sarcomatous components with either component capable of metastasis. Malignant epithelial components of salivary gland carcinosarcomas include squamous cell carcinoma and adenocarcinoma, whereas malignant mesenchymal components include chondrosarcoma, fibrosarcoma, leiomyosarcoma, osteosarcoma, and liposarcoma, in that order of frequency [1]. The most common metastatic sites include the lungs, bones, and central nervous system [24].
To date, 10 cases of carcinosarcoma of salivary glands with osteosarcomatous element have been published, of which only lung metastasis have been found [716]. We describe a case of carcinosarcoma arising in the parotid gland with an osteosarcomatous component which metastasized to abdominal cavity; to our knowledge, this is the first patient so described.

Case presentation

A 72-year-old man presented with a mass in the right parotid area that had become rapidly enlarged for 2 months. His medical history included a subtotal gastrectomy for a gastric ulcer 20 years earlier and low anterior resection for moderately differentiated adenocarcinoma of the rectum (Stage T1N0) 1 year earlier. Preoperative computed tomography (CT) showed a relatively well-defined heterogeneous enhancing solid lesion with calcification in the superficial lobe of the right parotid gland, with no indications of metastasis to the regional lymph nodes (Fig. 1).
Fine-needle aspiration specimen showed that the tumor contained many clusters of malignant epithelial cells and scattered atypical spindle cells on a necrotic background. Under suspicion of a malignant tumor, the patient underwent total parotidectomy. Gross examination of the specimen revealed a multifocal, ill-defined, grayish-white, and heterogeneous solid tumor, accompanied by calcification and measuring 3 × 2.5 cm. Microscopically, the tumor was composed of two malignant components, carcinoma (Fig. 2a, b) and sarcoma (Fig. 2c), with multifocal invasion (> 1.5 mm) of the capsule and adjacent tissues on a background of pre-existing pleomorphic adenoma (Fig. 2d). The carcinoma component of the tumor consisted of squamous cell carcinoma and poorly differentiated adenocarcinoma, whereas the sarcoma component consisted mainly of osteosarcoma, characterized by neoplastic bone and severe cellular anaplasia. Many mitotic figures and necrotic foci were observed. The external resection margin showed tumor involvement. Immunohistochemical staining showed that the carcinoma cells were positive for cytokeratin AE1/AE3 (Fig. 3a) and the osteosarcoma component was diffusely positive for vimentin (Fig. 3b). Both components showed some degree of nuclear immunoreactivity for p53 (Fig. 3c, d).
Following surgery, the patient received postoperative radiation therapy. Six months later, he complained of abdominal pain. Abdominal CT showed a distension of small bowel with luminal narrowing and localized high density material in the abdominal cavity (Fig. 4). The lesion was regarded as mechanical obstruction with postoperative adhesion because the patient had undergone previous abdominal surgery for rectal adenocarcinoma. After conservative management for several days, he experienced severe abdominal pain and an increased heart rate, and an emergency laparotomy was performed. Multiple hard calcified masses were observed in the abdominal walls, omentum, and mesentery, and mass excision with small bowel resection was done. On gross examination, bulky, gritty, and hemorrhagic mass adhered to the mesentery was identified (Fig. 5). Microscopically, the tumors were identified as osteogenic sarcomas, with histologic features identical to those of the osteosarcomatous component of the carcinosarcoma of the parotid gland (Fig. 6a). The tumor cells were positive for vimentin on immunohistochemical staining (Fig. 6b). Because of its rapid development over 6 months and no history of osteosarcoma at any sites, we concluded that the abdominal osteosarcoma was metastatic from the carcinosarcoma of the parotid gland. The patient was postoperatively admitted to the intensive care unit and died of acute respiratory distress syndrome (ARDS) caused by aspiration pneumonia.

Discussion and conclusions

Malignant mixed tumors of the salivary gland can describe three distinct histologic entities: carcinoma ex pleomorphic adenoma (the most common), metastasizing mixed tumor, and carcinosarcoma [1]. More than 99% of these tumors arise from pleomorphic adenomas, with only 0.2% being primary carcinosarcomas or true malignant mixed tumors [17]. Two hypotheses have been advanced to explain the histogenesis of carcinosarcoma. The convergence hypothesis suggests that these tumors are multiclonal and are derived from two or more types of mesenchymal and epithelial stem cells. The divergence hypothesis suggests that these tumors are monoclonal, with a single totipotent stem cell differentiating into epithelial and mesenchymal cells [18].
Surgery followed by radiation therapy may aid in the treatment of salivary carcinosarcoma. Despite treatment, over half of these patients die of local recurrence and/or metastasis and the average survival of these patients is 3.6 years [2, 7].
Only 10 cases of carcinosarcoma with osteosarcoma as the sarcomatous component have been reported. The clinicopathological features and outcomes of the reported cases are detailed in Table 1. Our reviews exhibited a male predominance (72.7%) with an age range of 35 to 83 years (median, 64 years). All cases had an adenocarcinoma as the carcinomatous component, and three cases also showed squamous cell carcinoma elements. The sarcomatous components other than osteosarcoma were chondrosarcomas, rhabdomyosarcomas, and fibrosarcomas. Of the 11 cases, 8 cases occurred in the parotid gland. All patients underwent surgical resection and 6 of them received radiotherapy and/or chemotherapy. Distant metastasis occurred in five cases, of which four cases involved the lung. In the present case, the sarcomatous component was an osteosarcoma, and the carcinomatous components were adenocarcinoma and squamous cell carcinoma. The tumor metastasized to the abdominal cavity by the osteosarcomatous component alone, which has not been reported to date.
Table 1
Review of previously reported cases of carcinosarcoma of the salivary glands with osteosarcoma components
Reference
Age (years)/sex
Location
Histologic type of carcinoma
Histologic type of sarcoma
Metastasis/site
Histologic type of metastatic tumor
Treatment
Outcome
Garner et al. 1989 [7]
57/F
Parotid gland
Adenocarcinoma
Osteosarcoma, chondrosarcoma
No
(−)
Left parotidectomy and radical neck dissection
Local recurrence at 6 weeks and died
Yamashita et al. 1990 [8]
52/M
Submandibular gland
Adenocarcinoma, squamous cell carcinoma
Osteosarcoma, chondrosarcoma, fibrosarcoma
No
(−)
Excision and right modified neck dissection with chemotherapy
No recurrence for 5 months
Bleiweiss et al. 1992 [9]
64/M
Submandibular gland
Adenocarcinoma
Osteosarcoma
No
(−)
Partial mandibulectomy with radical neck dissection
Local recurrence at 4 months
de la Torre et al. 1995 [10]
83/F
Parotid gland
Adenocarcinoma
Osteosarcoma, chondrosarcoma
Yes/lung
NR
Wide excision
Local recurrence and lung metastasis, died after 1 year
Carson et al. 1995 [11]
51/F
Parotid gland
Adenocarcinoma
Osteosarcoma
No
(−)
Total parotidectomy with chemotherapy
Local recurrence at 7 months and died at 9 months
Gogas et al. 1999 [12]
77/M
Submandibular gland
Salivary duct carcinoma
Osteosarcoma. chondrosarcoma, rhabdomyosarcoma
Yes/lung
NR
Wide excision with radiotherapy and chemotherapy
Lung metastasis at 3 months
Sironi et al. 2000 [13]
77/M
Parotid gland
Squamous cell carcinoma, adenocarcinoma,
Osteosarcoma
Yes/NR
NR
Right total parotidectomy with radical neck dissection
Metastasis at 3 months
Mardi et al. 2004 [14]
59/M
Parotid gland
Adenocarcinoma
Osteosarcoma, chondrosarcoma
NA
NA
NA
NA
Jang et al. 2011 [15]
67/M
Parotid gland
Adenocarcinoma
Osteosarcoma
Yes/lung
Osteosarcoma
Left parotidectomy with radiotherapy
Lung metastasis at 5 months
Jha et al.2017 [16]
35/M
Parotid gland
Adenocarcinoma
Osteosarcoma
No
(−)
Total radical parotidectomy with radiotherapy
No recurrence for 12 months
Present case
72/M
Parotid gland
Adenocarcinoma, squamous cell carcinoma
Osteosarcoma
Yes/abdominal cavity
Osteosarcoma
Total parotidectomy with radiotherapy
Metastasis at 6 months and died
NA, not available, NR not reported
The present patient underwent surgery and adjuvant radiotherapy. After 6 months, he complained of abdominal pain. At that time, the signs of small bowel obstruction with high density material in the abdominal cavity found on CT were regarded as an effect of his abdominal surgery for rectal adenocarcinoma 1 year earlier. Therefore, the management was only conservative, without surgery, and the possibility of metastasis from the salivary malignancy was overlooked. Later, rapid growth of the metastatic tumor resulted in an emergency laparotomy. Abdominal metastases of the mesentery, omentum, and peritoneum were observed. The patient experienced postoperative complications and died of ARDS.
We described a case of salivary gland carcinosarcoma harboring an osteosarcomatous component with abdominal metastasis consisted entirely of the sarcomatous element. Awareness of the possibility of abdominal metastasis by the sarcomatous component of salivary carcinosarcoma may help in managing patients with a history of abdominal surgery.

Availability of data and materials

All findings of this case report are based on diagnostic examinations performed during patient hospitalization. The publication of these data was authorized by Chungbuk National University Hospital. Data sharing is not applicable to this article as no datasets were generated or analyzed in the present report.
This study was approved by the Institutional Review Board of Chungbuk National University Hospital (2018-02-016).

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(Pt 1):279–328.PubMed Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(Pt 1):279–328.PubMed
2.
Zurück zum Zitat Stephen J, Batsakis JG, Luna MA, von der Heyden U, Byers RM. True malignant mixed tumors (carcinosarcoma) of salivary glands. Oral Surg Oral Med Oral Pathol. 1986;61:597–602.CrossRefPubMed Stephen J, Batsakis JG, Luna MA, von der Heyden U, Byers RM. True malignant mixed tumors (carcinosarcoma) of salivary glands. Oral Surg Oral Med Oral Pathol. 1986;61:597–602.CrossRefPubMed
3.
Zurück zum Zitat Alvarez-Canas C, Rodilla IG. True malignant mixed tumor (carcinosarcoma) of the parotid gland. Report of a case with immunohistochemical study Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:454–8.CrossRefPubMed Alvarez-Canas C, Rodilla IG. True malignant mixed tumor (carcinosarcoma) of the parotid gland. Report of a case with immunohistochemical study Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:454–8.CrossRefPubMed
4.
Zurück zum Zitat Harada H. Histomorphological investigation regarding to malignant transformation of pleomorphic adenoma (so-called malignant mixed tumor) of the salivary gland origin: special reference to carcinosarcoma. Kurume Med J. 2000;47:307–23.CrossRefPubMed Harada H. Histomorphological investigation regarding to malignant transformation of pleomorphic adenoma (so-called malignant mixed tumor) of the salivary gland origin: special reference to carcinosarcoma. Kurume Med J. 2000;47:307–23.CrossRefPubMed
5.
Zurück zum Zitat Kwon MY, Gu M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: a case report and review of the literature. Arch Pathol Lab Med. 2001;125:812–5.PubMed Kwon MY, Gu M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: a case report and review of the literature. Arch Pathol Lab Med. 2001;125:812–5.PubMed
6.
Zurück zum Zitat Taki NH, Laver N, Quinto T, Wein RO. Carcinosarcoma de novo of the parotid gland: case report. Head Neck. 2013;35:E161–3.CrossRefPubMed Taki NH, Laver N, Quinto T, Wein RO. Carcinosarcoma de novo of the parotid gland: case report. Head Neck. 2013;35:E161–3.CrossRefPubMed
7.
Zurück zum Zitat Garner SL, Robinson RA, Maves MD, Barnes CH. Salivary gland carcinosarcoma: true malignant mixed tumor. Ann Otol Rhinol Laryngol. 1989;98:611–4.CrossRefPubMed Garner SL, Robinson RA, Maves MD, Barnes CH. Salivary gland carcinosarcoma: true malignant mixed tumor. Ann Otol Rhinol Laryngol. 1989;98:611–4.CrossRefPubMed
8.
Zurück zum Zitat Yamashita T, Kameda N, Katayama K, Hiruta N, Nakada M, Takeda Y. True malignant mixed tumor of the submandibular gland. Acta Pathol Jpn. 1990;40:137–42.PubMed Yamashita T, Kameda N, Katayama K, Hiruta N, Nakada M, Takeda Y. True malignant mixed tumor of the submandibular gland. Acta Pathol Jpn. 1990;40:137–42.PubMed
9.
Zurück zum Zitat Bleiweiss IJ, Huvos AG, Lara J, Strong EW. Carcinosarcoma of the submandibular salivary gland. Immunohistochemical findings. Cancer. 1992;69:2031–5.CrossRefPubMed Bleiweiss IJ, Huvos AG, Lara J, Strong EW. Carcinosarcoma of the submandibular salivary gland. Immunohistochemical findings. Cancer. 1992;69:2031–5.CrossRefPubMed
10.
Zurück zum Zitat de la Torre M, Larsson E. Fine-needle aspiration cytology of carcinosarcoma of the parotid gland: cytohistological and immunohistochemical findings. Diagn Cytopathol. 1995;12:350–3.CrossRefPubMed de la Torre M, Larsson E. Fine-needle aspiration cytology of carcinosarcoma of the parotid gland: cytohistological and immunohistochemical findings. Diagn Cytopathol. 1995;12:350–3.CrossRefPubMed
11.
Zurück zum Zitat Carson HJ, Tojo DP, Chow JM, Hammadeh R, Raslan WF. Carcinosarcoma of salivary glands with unusual stromal components. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:738–46.CrossRefPubMed Carson HJ, Tojo DP, Chow JM, Hammadeh R, Raslan WF. Carcinosarcoma of salivary glands with unusual stromal components. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:738–46.CrossRefPubMed
12.
Zurück zum Zitat Gogas J, Markopoulos C, Karydakis V, Gogas G, Delladetsima J. Carcinosarcoma of the submandibular salivary gland. Eur J Surg Oncol. 1999;25:333–5.PubMed Gogas J, Markopoulos C, Karydakis V, Gogas G, Delladetsima J. Carcinosarcoma of the submandibular salivary gland. Eur J Surg Oncol. 1999;25:333–5.PubMed
13.
Zurück zum Zitat Sironi M, Isimbaldi G, Claren R, Delpiano C, Di Nuovo F, Spinelli M. Carcinosarcoma of the parotid gland: cytological, clinicopathological and immunohistochemical study of a case. Pathol Res Pract. 2000;196:511–7.CrossRefPubMed Sironi M, Isimbaldi G, Claren R, Delpiano C, Di Nuovo F, Spinelli M. Carcinosarcoma of the parotid gland: cytological, clinicopathological and immunohistochemical study of a case. Pathol Res Pract. 2000;196:511–7.CrossRefPubMed
14.
Zurück zum Zitat Mardi K, Sharma J. True malignant mixed tumor (carcinosarcoma) of parotid gland: a case report. Indian J Pathol Microbiol. 2004;47:64–6.PubMed Mardi K, Sharma J. True malignant mixed tumor (carcinosarcoma) of parotid gland: a case report. Indian J Pathol Microbiol. 2004;47:64–6.PubMed
15.
Zurück zum Zitat Jang SM, Jun YJ, Han H, Jang KS, Paik SS. Parotid gland carcinosarcoma with osteosarcoma as a sarcomatous component: a case report with fine needle aspiration cytologic findings. Korean J Pathol. 2011;45:412–6.CrossRef Jang SM, Jun YJ, Han H, Jang KS, Paik SS. Parotid gland carcinosarcoma with osteosarcoma as a sarcomatous component: a case report with fine needle aspiration cytologic findings. Korean J Pathol. 2011;45:412–6.CrossRef
16.
Zurück zum Zitat Jha V, Kolte S, Goyal S, Mandal AK. Osteosarcoma arising in carcinosarcoma de novo parotid gland in a young man: an unusual case with review of literature. J Clin Diagn Res. 2017;11:ED08–10.PubMedPubMedCentral Jha V, Kolte S, Goyal S, Mandal AK. Osteosarcoma arising in carcinosarcoma de novo parotid gland in a young man: an unusual case with review of literature. J Clin Diagn Res. 2017;11:ED08–10.PubMedPubMedCentral
17.
Zurück zum Zitat Owaki S, Kitano H, Hanada M, Asada Y, Sugihara H, Moritani S, Banba M. Carcinosarcoma of the submandibular gland: an autopsy case. Auris Nasus Larynx. 2003;30:439–42.CrossRefPubMed Owaki S, Kitano H, Hanada M, Asada Y, Sugihara H, Moritani S, Banba M. Carcinosarcoma of the submandibular gland: an autopsy case. Auris Nasus Larynx. 2003;30:439–42.CrossRefPubMed
18.
Zurück zum Zitat Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas).Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20:277–85.CrossRefPubMed Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas).Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20:277–85.CrossRefPubMed
Metadaten
Titel
Carcinosarcoma of the parotid gland with abdominal metastasis: a case report and review of literature
verfasst von
Chang Gok Woo
Seung-Myoung Son
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2018
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1406-6

Weitere Artikel der Ausgabe 1/2018

World Journal of Surgical Oncology 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.